Seminars in Nuclear Medicine

Article	Citations
Letter from the Editors	199
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques	143
Non-FDG hypoxia tracers	84
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update	81
FAPI-PET in Cardiovascular Disease	78
New targets of PET imaging for renal cancer	74
PET/CT in the Imaging of CNS Tumors	63
The Value of FDG PET/CT in Penile Cancer: An Update	57
Imaging of Invasive Fungal Infections- The Role of PET/CT	56
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies	55
New Promising Targets for Imaging in Cardiovascular Diseases	48
Theranostics in Lung Neuroendocrine Tumors	47
Sentinel Lymph Node Methods in Breast Cancer	45
Autoimmune Thyroid Diseases	44
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy	44
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer	41
Letter from the Editors	41
Imaging for Radiation Planning in Breast Cancer	41
Prognostic Value of PSMA PET/CT in Prostate Cancer	40
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled	37
Molecular Imaging in Inflammatory Bowel Disease	34
Artificial Intelligence for Drug Discovery: An Update and Future Prospects	34
CD70-Targeted Radiotheranostics: Now and Future	33
PET-CT radiomics for immunotherapy response	32
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity	32

The Role of Nuclear Medicine in Benign Thyroid Disease	32
The evolving role of nuclear medicine in osteomyelitis: A narrative review of current evidence and future horizons	32
Global experience in brain amyloid imaging	30
Total-Body PET/CT: A Role of Artificial Intelligence?	30
Imaging trends in diabetic foot infections	30
The Evolution of Artificial Intelligence in Nuclear Medicine	29
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma	28
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects	28
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects	27
Expanding Role for Gallium-68 PET Imaging in Oncology	27
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis	27
New Approaches for Imaging Bacteria	27
FDG PET for cardiac sarcoidosis: Protocol optimization, quantification, pitfalls, and multimodality imaging integration	27
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I	25
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects	25
Use of Radionuclide-Based Imaging Methods in Breast Cancer	25
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology	24
Letter From the Editors	24
Renography: Methods and Pitfalls	24
Update on Pediatric Nuclear Medicine in Acute Care	24
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices	23
Standardized PSMA-PET Imaging of Advanced Prostate Cancer	23
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases	22
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine	22
Practical approach to diuretic renography in children: Techniques, interpretation, and pitfalls	22
18F-Fluoride PET/CT—Updates	22
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma	22
Therapy strategies to defeat prostate cancer heterogeneity	21
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview	21
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review	21
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging	21
Nuclear Medicine Preclinical Research: The Role of Cell Cultures	21
The Clinical Utility of Molecular Imaging in COVID-19: An Update	20
Radiolabeled Somatostatin Analogs for Cancer Imaging	20
Functional Imaging of Testicular Torsion	20
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?	20
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends	20
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine	20
FDG PET/CT for Staging Lung Carcinoma: An Update	20
Artificial Intelligence Augmented Cerebral Nuclear Imaging	19
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?	19
Letter from the Editors	19
Targeted Radiopharmaceutical Therapy for Bone Metastases	19
The role of nuclear medicine in abdominopelvic infections	19
Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma	18
Sentinel Node Mapping in Penile Cancer: An Update on Methods and Pitfalls	18
Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature	18
Artificial Intelligence and Workforce Diversity in Nuclear Medicine	17
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma	17
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET	17

Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)	17
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace	17
RETRACTED: Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine	16
Prostate Cancer Theranostics With 177Lu-PSMA	16
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5	16
A Role of Non-FDG Tracers in Lung Cancer?	16
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma	16
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides	16
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging	15
Radiolabeled Antibody–Drug Conjugates in the Treatment of Solid Tumors	15
Neuroimaging of Mild Traumatic Injury	15
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System	15
Advances and challenges of PET imaging in bladder cancer–An update and future trends	15
Letter From the Guest Editors	15
Letter From the Editors	14
How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers	14
Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN)	14
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence	14
Cardiac PET/MRI: Recent Developments and Future Aspects	14
Letter From the Editors	13
Preclinical Evaluation of Novel PET Probes for Dementia	13
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational	13
The role of cardiac PET imaging in cardiac amyloidosis	13
PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis	13
Cardiovascular Imaging in Women	13
Letter from the Editors	13
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging	13
Letter from the Editors	13
Positron emission tomography imaging of inflammation and infection in children: an update	13
Letter from the Editors	13
Total Body PET/CT: A Role in Musculoskeletal Diseases	13
New Targets for Imaging in Nuclear Medicine	12
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases	12
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update	12
FDG PET/CT for Staging and Restaging Malignant Mesothelioma	12
Insights into the Global Practice of Paediatric Renal Scintigraphy Studies	12
Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce	12
Response assessment in advanced differentiated thyroid cancer	12
Letter from the Editors	12
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer	12
Current status on imaging invasive fungal infections with positron emission tomography	12
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy	12
Parathyroid Imaging	12
Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[18F]FDG-PET/CT, 18F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone	12
Radiopharmaceuticals for imaging T-cells	11
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?	11
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies	11
Pitfalls of Radionuclide Renal Imaging in Pediatrics	11
Current and Future Perspectives of PDL1 PET and SPECT Imaging	11
Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging	11
Glypican-3: Novel Theranostic Agent for Hepatocellular Carcinoma	11
AI in SPECT Imaging: Opportunities and Challenges	11
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update	10
PET imaging of polymyalgia rheumatica: update and future trends	10
Imaging of Bone Metastases in Breast Cancer	10
New Targets for Positron Emission Tomography Imaging in Parkinson´s Disease	10
The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update	10
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review	10
Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access	10
Molecular imaging Theranostics of Neuroendocrine Tumors	10
Imaging of infection in Nephro-urology: A practical nuclear medicine–focused review	10
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers	9
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?	9
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma	9
Imaging Approach to Disease of the Pleura	9
Standardization of infection [18F]FDG-PET/CT imaging protocols and reporting criteria	9
Combination Strategies and Targeted Radionuclide Therapies	9
Letter from the Editors	9
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer	9
Advances in PSMA Alpha Theragnostics	9
Quantification, radiomics and artificial intelligence in infection imaging: Current status and future directions in nuclear medicine	9
FDG PET/CT Imaging of Sarcoidosis	8
Letter From the Editors	8
Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends	8
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma	8
Letter From the Editors	8
The Current Role of Tau PET Imaging in Neurodegeneration	8
Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care	8
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer	8
Application of Deep Learning in Breast Cancer Imaging	8

Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain	8
Re-defining the 3Rs of pre-clinical research in nuclear medicine	8
New targets for PET imaging of inflammation	8
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review	8
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging	7
Renal Scintigraphy in Adults: An Update	7
18F-FDG PET/CT for Response Assessment in Lung Cancer	7
The Role of FAPI PET/CT in the Assessment of Inflammatory Diseases	7
The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer	7
Molecular Imaging of Tuberculosis	7
PET/CT in Bladder Cancer: An Update	7
Total Body PET-CT Protocols in Oncology	7
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma	7
Molecular Imaging of Fever of Unknown Origin: An Update	7
Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting	7
Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer	7
The Impact of Radiopharmaceutical Therapy on Renal Function	7
FAP in cardiovascular pathophysiology: Advances in non-invasive imaging and therapeutic targeting for myocardial fibrosis	7
Clinical implementation of RECIP 1.0	7
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update	7
Updates on tuberculosis imaging	7
Letter from the Editors	6
Total-Body PET/CT: Pros and Cons	6
Potential of Technetium and Rhenium Theranostics	6
How to Report PSMA PET	6
Present status and future trends in molecular imaging of lymphocytes	6
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies	6
[18F]FDG PET/CT imaging in Polyarteritis Nodosa-spectrum vasculitis	6
Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?	6
Molecular Imaging of Pituitary Tumors	6
The role of non-FDG agents in PET imaging of bladder cancer	6
PET/CT in Hodgkin Lymphoma: An Update	6
18F-FDG PET/CT in the evaluation of suspected infections following cardiothoracic surgical interventions	6
Impact of PSMA PET on Radiation Oncology Planning	6
Vulnerable Plaque Imaging	6
Mucin-Targeted Antibodies for Ovarian Cancer	6
The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art	6